ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Powder Hemostatic Agent Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-6Y7713
Home | Market Reports | Health| Medical Devices & Equipment
Global Powder Hemostatic Agent Market Insights Forecast to 2028
BUY CHAPTERS

Global Powder Hemostatic Agent Market Research Report 2025

Code: QYRE-Auto-6Y7713
Report
August 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson (Ethicon)
Celox Medical
Amed Therapeutics
CryoLife
BioCer Entwicklungs-GmbH.
Yunnan Baiyao
HHAO TECHNOLOGY
Johnson & Johnson (Ethicon)

Powder Hemostatic Agent Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Powder Hemostatic Agent Market

Powder Hemostatic Agent Market

The global market for Powder Hemostatic Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A powdered medicament that can stop bleeding when the body bleeds
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Powder Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powder Hemostatic Agent.
The Powder Hemostatic Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Powder Hemostatic Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Powder Hemostatic Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Powder Hemostatic Agent Market Report

Report Metric Details
Report Name Powder Hemostatic Agent Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson（Ethicon）, Celox Medical, Amed Therapeutics, Cryolife, BioCer Entwicklungs-GmbH, Yunnan Baiyao, HHAO TECHNOLOGY
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Powder Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Powder Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Powder Hemostatic Agent Market report?

Ans: The main players in the Powder Hemostatic Agent Market are Johnson & Johnson（Ethicon）, Celox Medical, Amed Therapeutics, Cryolife, BioCer Entwicklungs-GmbH, Yunnan Baiyao, HHAO TECHNOLOGY

What are the Application segmentation covered in the Powder Hemostatic Agent Market report?

Ans: The Applications covered in the Powder Hemostatic Agent Market report are Hospitals, Clinics, Home Care

What are the Type segmentation covered in the Powder Hemostatic Agent Market report?

Ans: The Types covered in the Powder Hemostatic Agent Market report are Absorbable Hemostatic Agent, Not Absorbable Hemostatic Agent

Recommended Reports

Hemostatic Agents

Specialty Hemostats

Absorbable & Polysaccharide

1 Powder Hemostatic Agent Market Overview
1.1 Product Definition
1.2 Powder Hemostatic Agent by Type
1.2.1 Global Powder Hemostatic Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Powder Hemostatic Agent by Application
1.3.1 Global Powder Hemostatic Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Powder Hemostatic Agent Market Size Estimates and Forecasts
1.4.1 Global Powder Hemostatic Agent Revenue 2020-2031
1.4.2 Global Powder Hemostatic Agent Sales 2020-2031
1.4.3 Global Powder Hemostatic Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Powder Hemostatic Agent Market Competition by Manufacturers
2.1 Global Powder Hemostatic Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Powder Hemostatic Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Powder Hemostatic Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Powder Hemostatic Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Powder Hemostatic Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Powder Hemostatic Agent, Product Type & Application
2.7 Global Key Manufacturers of Powder Hemostatic Agent, Date of Enter into This Industry
2.8 Global Powder Hemostatic Agent Market Competitive Situation and Trends
2.8.1 Global Powder Hemostatic Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Powder Hemostatic Agent Players Market Share by Revenue
2.8.3 Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Powder Hemostatic Agent Market Scenario by Region
3.1 Global Powder Hemostatic Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Powder Hemostatic Agent Sales by Region: 2020-2031
3.2.1 Global Powder Hemostatic Agent Sales by Region: 2020-2025
3.2.2 Global Powder Hemostatic Agent Sales by Region: 2026-2031
3.3 Global Powder Hemostatic Agent Revenue by Region: 2020-2031
3.3.1 Global Powder Hemostatic Agent Revenue by Region: 2020-2025
3.3.2 Global Powder Hemostatic Agent Revenue by Region: 2026-2031
3.4 North America Powder Hemostatic Agent Market Facts & Figures by Country
3.4.1 North America Powder Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Powder Hemostatic Agent Sales by Country (2020-2031)
3.4.3 North America Powder Hemostatic Agent Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Powder Hemostatic Agent Market Facts & Figures by Country
3.5.1 Europe Powder Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Powder Hemostatic Agent Sales by Country (2020-2031)
3.5.3 Europe Powder Hemostatic Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Powder Hemostatic Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Powder Hemostatic Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Powder Hemostatic Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Powder Hemostatic Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Powder Hemostatic Agent Market Facts & Figures by Country
3.7.1 Latin America Powder Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Powder Hemostatic Agent Sales by Country (2020-2031)
3.7.3 Latin America Powder Hemostatic Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Powder Hemostatic Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Powder Hemostatic Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Powder Hemostatic Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Powder Hemostatic Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Powder Hemostatic Agent Sales by Type (2020-2031)
4.1.1 Global Powder Hemostatic Agent Sales by Type (2020-2025)
4.1.2 Global Powder Hemostatic Agent Sales by Type (2026-2031)
4.1.3 Global Powder Hemostatic Agent Sales Market Share by Type (2020-2031)
4.2 Global Powder Hemostatic Agent Revenue by Type (2020-2031)
4.2.1 Global Powder Hemostatic Agent Revenue by Type (2020-2025)
4.2.2 Global Powder Hemostatic Agent Revenue by Type (2026-2031)
4.2.3 Global Powder Hemostatic Agent Revenue Market Share by Type (2020-2031)
4.3 Global Powder Hemostatic Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Powder Hemostatic Agent Sales by Application (2020-2031)
5.1.1 Global Powder Hemostatic Agent Sales by Application (2020-2025)
5.1.2 Global Powder Hemostatic Agent Sales by Application (2026-2031)
5.1.3 Global Powder Hemostatic Agent Sales Market Share by Application (2020-2031)
5.2 Global Powder Hemostatic Agent Revenue by Application (2020-2031)
5.2.1 Global Powder Hemostatic Agent Revenue by Application (2020-2025)
5.2.2 Global Powder Hemostatic Agent Revenue by Application (2026-2031)
5.2.3 Global Powder Hemostatic Agent Revenue Market Share by Application (2020-2031)
5.3 Global Powder Hemostatic Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson（Ethicon）
6.1.1 Johnson & Johnson（Ethicon） Company Information
6.1.2 Johnson & Johnson（Ethicon） Description and Business Overview
6.1.3 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product Portfolio
6.1.5 Johnson & Johnson（Ethicon） Recent Developments/Updates
6.2 Celox Medical
6.2.1 Celox Medical Company Information
6.2.2 Celox Medical Description and Business Overview
6.2.3 Celox Medical Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Celox Medical Powder Hemostatic Agent Product Portfolio
6.2.5 Celox Medical Recent Developments/Updates
6.3 Amed Therapeutics
6.3.1 Amed Therapeutics Company Information
6.3.2 Amed Therapeutics Description and Business Overview
6.3.3 Amed Therapeutics Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Amed Therapeutics Powder Hemostatic Agent Product Portfolio
6.3.5 Amed Therapeutics Recent Developments/Updates
6.4 Cryolife
6.4.1 Cryolife Company Information
6.4.2 Cryolife Description and Business Overview
6.4.3 Cryolife Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cryolife Powder Hemostatic Agent Product Portfolio
6.4.5 Cryolife Recent Developments/Updates
6.5 BioCer Entwicklungs-GmbH
6.5.1 BioCer Entwicklungs-GmbH Company Information
6.5.2 BioCer Entwicklungs-GmbH Description and Business Overview
6.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product Portfolio
6.5.5 BioCer Entwicklungs-GmbH Recent Developments/Updates
6.6 Yunnan Baiyao
6.6.1 Yunnan Baiyao Company Information
6.6.2 Yunnan Baiyao Description and Business Overview
6.6.3 Yunnan Baiyao Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yunnan Baiyao Powder Hemostatic Agent Product Portfolio
6.6.5 Yunnan Baiyao Recent Developments/Updates
6.7 HHAO TECHNOLOGY
6.7.1 HHAO TECHNOLOGY Company Information
6.7.2 HHAO TECHNOLOGY Description and Business Overview
6.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Product Portfolio
6.7.5 HHAO TECHNOLOGY Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Powder Hemostatic Agent Industry Chain Analysis
7.2 Powder Hemostatic Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Powder Hemostatic Agent Production Mode & Process Analysis
7.4 Powder Hemostatic Agent Sales and Marketing
7.4.1 Powder Hemostatic Agent Sales Channels
7.4.2 Powder Hemostatic Agent Distributors
7.5 Powder Hemostatic Agent Customer Analysis
8 Powder Hemostatic Agent Market Dynamics
8.1 Powder Hemostatic Agent Industry Trends
8.2 Powder Hemostatic Agent Market Drivers
8.3 Powder Hemostatic Agent Market Challenges
8.4 Powder Hemostatic Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson (Ethicon)
Celox Medical
Amed Therapeutics
CryoLife
BioCer Entwicklungs-GmbH.
Yunnan Baiyao
HHAO TECHNOLOGY
Johnson & Johnson (Ethicon)
List of Tables
 Table 1. Global Powder Hemostatic Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Powder Hemostatic Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Powder Hemostatic Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Powder Hemostatic Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Powder Hemostatic Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Powder Hemostatic Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Powder Hemostatic Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Powder Hemostatic Agent Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Powder Hemostatic Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Powder Hemostatic Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Powder Hemostatic Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Powder Hemostatic Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Powder Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powder Hemostatic Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Powder Hemostatic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Powder Hemostatic Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Powder Hemostatic Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Powder Hemostatic Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Powder Hemostatic Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Powder Hemostatic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Powder Hemostatic Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Powder Hemostatic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Powder Hemostatic Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Powder Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Powder Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Powder Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Powder Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Powder Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Powder Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Powder Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Powder Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Powder Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Powder Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Powder Hemostatic Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Powder Hemostatic Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Powder Hemostatic Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Powder Hemostatic Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Powder Hemostatic Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Powder Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Powder Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Powder Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Powder Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Powder Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Powder Hemostatic Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Powder Hemostatic Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Powder Hemostatic Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Powder Hemostatic Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Powder Hemostatic Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Powder Hemostatic Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Powder Hemostatic Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Powder Hemostatic Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Powder Hemostatic Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Powder Hemostatic Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Powder Hemostatic Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Powder Hemostatic Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Powder Hemostatic Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Powder Hemostatic Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Powder Hemostatic Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Powder Hemostatic Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Powder Hemostatic Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Powder Hemostatic Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Powder Hemostatic Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Powder Hemostatic Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Powder Hemostatic Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson（Ethicon） Company Information
 Table 71. Johnson & Johnson（Ethicon） Description and Business Overview
 Table 72. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product
 Table 74. Johnson & Johnson（Ethicon） Recent Developments/Updates
 Table 75. Celox Medical Company Information
 Table 76. Celox Medical Description and Business Overview
 Table 77. Celox Medical Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Celox Medical Powder Hemostatic Agent Product
 Table 79. Celox Medical Recent Developments/Updates
 Table 80. Amed Therapeutics Company Information
 Table 81. Amed Therapeutics Description and Business Overview
 Table 82. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Amed Therapeutics Powder Hemostatic Agent Product
 Table 84. Amed Therapeutics Recent Developments/Updates
 Table 85. Cryolife Company Information
 Table 86. Cryolife Description and Business Overview
 Table 87. Cryolife Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Cryolife Powder Hemostatic Agent Product
 Table 89. Cryolife Recent Developments/Updates
 Table 90. BioCer Entwicklungs-GmbH Company Information
 Table 91. BioCer Entwicklungs-GmbH Description and Business Overview
 Table 92. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product
 Table 94. BioCer Entwicklungs-GmbH Recent Developments/Updates
 Table 95. Yunnan Baiyao Company Information
 Table 96. Yunnan Baiyao Description and Business Overview
 Table 97. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Yunnan Baiyao Powder Hemostatic Agent Product
 Table 99. Yunnan Baiyao Recent Developments/Updates
 Table 100. HHAO TECHNOLOGY Company Information
 Table 101. HHAO TECHNOLOGY Description and Business Overview
 Table 102. HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. HHAO TECHNOLOGY Powder Hemostatic Agent Product
 Table 104. HHAO TECHNOLOGY Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Powder Hemostatic Agent Distributors List
 Table 108. Powder Hemostatic Agent Customers List
 Table 109. Powder Hemostatic Agent Market Trends
 Table 110. Powder Hemostatic Agent Market Drivers
 Table 111. Powder Hemostatic Agent Market Challenges
 Table 112. Powder Hemostatic Agent Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Powder Hemostatic Agent
 Figure 2. Global Powder Hemostatic Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Powder Hemostatic Agent Market Share by Type: 2024 & 2031
 Figure 4. Absorbable Hemostatic Agent Product Picture
 Figure 5. Not Absorbable Hemostatic Agent Product Picture
 Figure 6. Global Powder Hemostatic Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Powder Hemostatic Agent Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Home Care
 Figure 11. Global Powder Hemostatic Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Powder Hemostatic Agent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Powder Hemostatic Agent Sales (2020-2031) & (K Units)
 Figure 14. Global Powder Hemostatic Agent Average Price (USD/Unit) & (2020-2031)
 Figure 15. Powder Hemostatic Agent Report Years Considered
 Figure 16. Powder Hemostatic Agent Sales Share by Manufacturers in 2024
 Figure 17. Global Powder Hemostatic Agent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Powder Hemostatic Agent Players: Market Share by Revenue in Powder Hemostatic Agent in 2024
 Figure 19. Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Powder Hemostatic Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Powder Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 22. North America Powder Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Powder Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 26. Europe Powder Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Powder Hemostatic Agent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Powder Hemostatic Agent Revenue Market Share by Region (2020-2031)
 Figure 34. China Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Powder Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Powder Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Powder Hemostatic Agent Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Powder Hemostatic Agent Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Powder Hemostatic Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Powder Hemostatic Agent by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Powder Hemostatic Agent by Type (2020-2031)
 Figure 56. Global Powder Hemostatic Agent Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Powder Hemostatic Agent by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Powder Hemostatic Agent by Application (2020-2031)
 Figure 59. Global Powder Hemostatic Agent Price (USD/Unit) by Application (2020-2031)
 Figure 60. Powder Hemostatic Agent Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025
Global Hemostatic Agents Market Research Report 2025
Global Medical Absorbable Hemostatic Powder Market Insights Forecast to 2030
Medical Hemostatic Powders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Surgery Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Wound Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Absorbable Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Disposable Hemostatic Agents Market Insights Forecast to 2030
Absorbable Surgical Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Active Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Endoscopic Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Absorbable Hemostat Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Hemostatic Powder and Hemostatic Gauze Market Research Report 2025
Global Hemostatic Agents and Tissue Sealants Market Research Report 2025
Global Hemostatic Pad Market Insights Forecast to 2030
Chitosan Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Emergency Hemostatic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biodegradable Hemostatic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Based Absorbable Surgical Hemostatic Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global General Surgery Hemostatic Agents Market Research Report 2024

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions